menu Home

Program - Day 2 (Nov. 9)

Room 1


Time Program Chair / Speaker
08:40-09:00 Opening Remark Kwangsung Park
(President of the 40th Korea-Japan Urological Congress (KJUC))
Congratulatory Remarks Jun Hyuk Hong
(President of the Korean Urological Association (KUA))
Masatoshi Eto
(President of the Japanese Urological Association (JUA))
09:00-10:30 Urological Oncology I : Prostate Hanjong Ahn
(Asan Medical Center, Korea)
Masatoshi Eto
(Kyushu University, Japan)
Optimization of diagnosis and management for pathological N1 after radical prostatectomy Masaki Shiota
(Kyushu University, Japan)
Intratumoral microbiome & prostate cancer Seok Joong Yun
(Chungbuk National University, Korea)
PSMA theranostics: Current evidence and our experience Takafumi Yanagisawa
(Jikei University, Japan)
Practice changing clinical trials in the management of prostate cancer Seong Hyeon Yu
(Chonnam National University, Korea)
Panel Discussion Ho Seok Chung
(Chonnam National University, Korea)
10:30-11:00 Coffee Break
11:00-12:30 Endourology & Robotics I Gyung Tak Mario Sung
(Dong-A University, Korea)
Atsushi Takenaka
(Tottori University, Japan)
Clinical experience of radical cystectomy using Hinotori surgical robot system Koji Chiba
(Kobe University, Japan)
Clinical experience of robot radical cystectomy with ICUD Seok Ho Kang
(Korea University, Korea)
Challenging RAPN for cystic-RCC (T2 over) Kenji Zennami
(Fujita Medical University, Japan)
Challenging cases of robotic upper tract reconstruction Young Eun Yoon
(Hanyang University, Korea)
Panel Discussion Tae Hyo Kim
(Pusan National University, Korea)
Ill Young Seo
(Wonkwang University, Korea)
12:30-13:30 Lunch
Korea-Japan Organizing Committee Meeting
(13:00-13:20 , Room2)
 
13:30-14:30 Prostate I: Recent Advancements to Optimize Patients with mHSPC? Tomonori Habuchi
(Akita University, Japan)
Jun Hyuk Hong
(University of Ulsan, Korea)
Treatment options for mHSPC, advances and barriers Jae Seung Chung
(Inje University, Korea)
Should the primary lesion be treated in synchronous mHSPC? Naoki Terada
(Fukui University, Japan)
Which patients with mHSPC should get triplet systemic therapy? Jae Young Joung
(National Cancer Center, Korea)
Panel Discussion Soo Dong Kim
(Dong-A University, Korea)
Kang Su Cho
(Yonsei University, Korea)
14:30-15:30 Voiding Dysfunction II: Mastering SUI: Advanced Insights into Sling Surgery Solutions Kyu Sung Lee
(Sungkyunkwan University, Korea)
Masashi Honda
(Tottori University, Japan)
Advancing Continence: A Comprehensive Exploration of Sling Surgery in Postprostatectomy Incontinence Management Jisung Shim
(Korea University, Korea)
Untangling the Mesh: Evaluating Women's Outcomes After Mid-Urethral Sling Mesh Correction Kang Jun Cho
(Catholic University, Korea)
Tips for Treatment and Postoperative Observation of SUI Akane Yamaguchi
(Tsukuba University, Japan)
Panel Discussion Dong Gil Shin
(Pusan National University, Korea)
Yong-Gil Na
(Chungnam National University, Korea)
15:30-16:00 Coffee Break  
16:00-17:30 Urological Oncology II: Kidney Hiroshi Kitamura
(Toyama University, Japan)
Seongil Seo
(Sungkyunkwan University, Korea)
Current role of Active Surveillance for Small Renal Mass: Benefits and risks Takahiro Osawa
(Hokkaido University, Japan)
Stereotactic body radiation therapy for patients with renal cell carcinoma Cheryn Song
(University of Ulsan, Korea)
Future of adjuvant therapy in renal cell carcinoma Takayuki Sumiyoshi
(Kyoto University, Japan)
Trends of utilization of systemic therapies for advanced / metastatic renal cell carcinoma Jung Kwon Kim
(University of Ulsan, Korea)
Panel Discussion Eu Chang Hwang
(Chonnam National University, Korea)
17:30-17:45 Presentation Awards and Closing Remarks
19:00-21:00 Presidential Dinner

Room 2


Time Program Chair / Speaker
09:00-10:30 Microbiome, Urological disease, and Biological therapeutics Seung-Ju Lee
(Catholic University, Korea)
Hideki Enokida
(Kagoshima University, Japan)
Vaginal microbiome and recurrent cystitis Takuya Sadahira
(Okayama University Hospital, Japan)
Urinary microbiome, OAB and IC/PBS Jung Hoon Kim
(Chung-Ang University, Korea)
Cancer immunotherapy with probiotics for urothelial carcinoma in Kagoshima university Hirofumi Yoshino
(Kagoshima University, Japan)
Microbiome and biological therapeutics: Phage therapy Woong Bin Kim
(Soonchunhyang University, Korea)
Panel Discussion Joon Hwa Noh
(Kwangju Christian Hospital, Korea)
Dong Hoon Lim
(Chosun University, Korea)
10:30-11:00 Coffee Break  
11:00-12:30 Voiding Dysfunction I: Advanced Clinical Practice: Botulinum toxin A Intradetrusor Injection Mastery Jang Hwan Kim
(Yonsei University, Korea)
Naoya Masumori
(Sapporo Medical University, Japan)
Unlocking the Power: Botox's Mechanisms in Overactive Bladder Treatment Hyeonwoo Kim
(Pusan National University, Korea)
Optimizing Patient Care: Enhancing Bladder Function Assessment for Procedural Success Sun-Ouck Kim
(Chonnam National University, Korea)
Precision and Safety: Expert Strategies for Perfecting Injection Technique Masashi Honda
(Tottori University, Japan)
Navigating Treatment Challenges: Effective Strategies for Refractory Cases Hiromitsu Negoro
(Tsukuba University, Japan)
Panel Discussion Young-Suk Lee
(Sungkyunkwan University, Korea)
12:30-13:30 Lunch
Korea-Japan Organizing Committee Meeting
(13:00-13:20)
 
13:30-14:30 Urological Oncology III: Urothelial Tae Gyun Kwon
(Kyungpook National University, Korea)
Hiroyuki Nishiyama
(University of Tsukuba, Japan)
Merging urinary biomarkers for the detection and surveillance of urothelial carcinoma Makito Miyake
(Nara University, Japan)
Impact of Artificial Intelligence on practices for urological malignancy Atsushi Ikeda
(Tsukuba University, Japan)
Novel antibody-drug conjugates (ADC) and combination therapy in urothelial carcinoma Ho Kyung Seo
(National Cancer Center, Korea)
Panel Discussion Taek Won Kang
(Chonnam National University, Korea)
14:30-15:30 Prostate II: Biochemical recurrence after primary definitive therapy Sung Kyu Hong
(Seoul National University, Korea)
Takahiro Kimura
(Jikei University, Japan)
Treatment options for BCR Takafumi Yanagisawa
(Jikei University, Japan)
Salvage radiotherapy for biochemical recurrence after radical prostatectomy Chan Woo Wee
(Department of Radiation Oncology, Yonsei University, Korea)
After External Beam Radiation Therapy Byung Hoon Kim
(Keimyung University, Korea)
Panel Discussion Seung Chol Park
(Wonkwang University, Korea)
Tae Nam Kim
(Pusan National University, Korea)
15:30-16:00 Coffee Break  
16:00-17:30 Endourology & Robotics II Dong Deuk Kwon
(Chonnam National University, Korea)
Mikio Sugimoto
(Kawaga University, Japan)
Oral chemolytic therapy for renal stone: Myth and Truth Rei Unno
(Nagoya City University, Japan)
Clinical experience of RIRS under local anesthesia Sang Hyub Lee
(Kyunghee University, Korea)
Tips and Tricks of supine ECIRS for complicated renal stones Takaaki Inoue
(Hara Genitourinary Hospital, Japan)
Clinical experience of novel robot-assisted RIRS Deok Hyun Han
(Sungkyunkwan University, Korea)
Panel Discussion Joo Yong Lee
(Yonsei University, Korea)
Bum Soo Kim
(Kyungpook National University, Korea)
19:00-21:00 Presidential Dinner

Room 3


Time Program Chair / Speaker
09:00-10:30 Poster session I Chikara Ohyama
(Hirosaki University, Japan)
Byong Chang Jeong
(Sungkyunkwan University, Korea)
PS1-01 Preoperative inadequate control of hypertension is associated with graft survival after renal transplantation Yohei Abe
(Kagawa University, Japan)
PS1-02 Evaluation of surgical technique in transurethral resection of bladder tumor using the Operative Performance Rating System Kana Kohashiguchi
(Kagawa University, Japan)
PS1-03 Withdrawal

The update of the neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicenter retrospective study
Shingo Hatakeyama
(Hirosaki University, Japan)
PS1-04 The update of the neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a comarison by tumor site Tomoko Hamaya
(Hirosaki University, Japan)
PS1-05 Lung immune prognostic index is a predictor of response to immune checkpoint inhibitor therapy for advanced renal cancer Noriya Yamaguchi
(Tottori University, Japan)
PS1-06 Therapeutic strategies for renal cell carcinoma targeting HSF4 Saeki Saito
(Kagoshima University, Japan)
PS1-07 Can expression for AURKA serve as a prognostic factor in advanced RCC treated with immune checkpoint inhibitors (ICIs) in first line therapy? Yukiya Odagiri
(University of Toyama, Japan)
PS1-08 Withdrawal

A prospective, open-label study on additive effect of combined administration of an anti-muscarinic agent and a vitamin D formula on improvement of overactive bladder and vitamin D deficiency, compared to administration of an anti-muscarinic agent alone.
Hoyoung BAE
(Seoul National University, Korea)
PS1-09 A prospective, double-blind study on additive effect of combined administration of an anti-muscarinic agent and a vitamin D formula on improvement of overactive bladder and vitamin D deficiency, compared to administration of an anti-muscarinic agent alone. Hoyoung BAE
(Seoul National University, Korea)
11:00-12:30 Poster session II Seung Il Jung
(Chonnam National University, Korea)
Masayuki Nakagawa
(Kagoshima University, Japan)
PS2-01 Short-term clinical outcomes and adverse events of proton beam therapy for prostate cancer: effect of hydrogel spacer placement Tatsuki Miyamoto
(Takai Hospital, Japan)
PS2-02 Bladder preservation with concurrent chemoradiotherapy for muscle-invasive bladder cancer: A multicenter-based outcomes of 37 patients Yusuke Iemura
(Yamatotakada Municipal Hospital, Japan)
PS2-03 Mesonephric adenoma diagnosed after surgery for renal pelvis tumor Misaki Shiba
(Toyama University, Japan)
PS2-04 Clinical study of erectile dysfunction in patients aged 65 and older HARUAKI SASAKI
(Showa University, Japan)
PS2-05 Sperm Preservation Achievements of Young Cancer Patients in Kanagawa Prefecture (Japan) in the Fertility Preservation Regional Network "Kanaofu Net". Yasushi Yumura
(Yokohama City University, Japan)
PS2-06 Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: A real-world data analysis Nobutaka Nishimura
(Nara Medical University, Japan)
PS2-07 The Role of DNA Methylation in Prostate Cancer Heterogeneity Kei Mizuno
(Kyoto University, Japan)
PS2-08 Nationwide Surveillance of Antimicrobial Resistance in Uncomplicated Cystitis in 2023: Conducted by the Korean Association of Urogenital Tract Infection and Inflammation (KAUTII) Seong Hyeon Yu
(Chonnam National University, Korea)
PS2-09 Antimicrobial Resistance of E.coli for Uncomplicated Cystitis : Conducted by the Korean Association of Urogenital Tract Infection and Inflammation (KAUTII) Seong Hyeon Yu
(Chonnam National University, Korea)
12:30-13:30 Lunch
Korea-Japan Organizing Committee Meeting
(13:00-13:20 , Room2)
 
13:30-15:00 Poster session III Jong Kwan Park
(Jeonbuk National University, Korea)
Kyung-Jin Oh
(Chonnam National University, Korea)
PS3-01 Efficacy and Safety of Enfortumab Vedotin for Metastatic Urothelial Carcinoma at Kyushu University Koichi Shiraishi
(Kyushu University, Japan)
PS3-02 Large-scale genetic analysis of Upper Urinary Tract Urothelial Carcinoma in Japanese Yuya Sekine
(Akita University, Japan)
PS3-03 Robot-assisted radical nephroureterectomy using a hinotori surgical robot system: Report of first series of four cases Takahiro Hoshino
(Tottori University, Japan)
PS3-04 The Safety of Total Cystectomy in Elderly Patients Using the Japanese Diagnosis Procedure Combination Per-Diem Payment System Database Ryota Funato
(Nippon Medical School, Japan)
PS3-05 Measurement of recovery rate of penile neuropathy after surgical treatment of Peyronie's disease using biothesiometry Dae Yul Yang
(Hallym University, Korea)
PS3-06 Withdrawal

Impact of Myosteatosis on Survival in Fournier Gangrene: An AI-Driven CT Study
Byeong Jin Kang
(Pusan National University, Korea)
PS3-07 Comparative Analysis of TKI Monotherapy Versus ICI Combination Therapy in First-Line Treatment of Advanced Renal Cell Carcinoma Wonseok Seo
(Fukui University, Japan)
PS3-08 Withdrawal

Efficacy and safety of analgesic-eluting urethral catheter after urogynecologic surgery: A prospective randomized controlled trial
Hwanik Kim
(Hallym University, Korea)
19:00-21:00 Presidential Dinner
go to top

COPYRIGHT(C) BY The 40th KOREA-JAPAN Urological Congress.

Gaon Convention Services, Inc.
ADDRESS: ROOM 301, 347, HWAGOK-RO, GANGSEO-GU, SEOUL, REPUBLIC OF KOREA.
TEL : +82-2-6956-7989   |   E-MAIL : gaonpco@gaonpco.com

close

사전등록

등록구분
근무처
소속의사회

* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.